ASI Life Sciences Introduces Disposable Heat Exchanger and Mixer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ASI Life Sciences Introduces Disposable Heat Exchanger and Mixer


ASI–Life Sciences introduced the DHX Disposable Heat Exchanger and the imPULSE MDS mixing, docking, and shipping system for single-use biopharmaceutical processes.

The DHX Heat Exchanger is a modular system based on the widely accepted industry-standard plate-and-frame design that uses bags to create a sterile fluid path. These bags fit tightly between five stainless-steel plates. The process fluid flows through the single-use bags, while the heating or cooling fluid runs in a counter-current flow through the plates in a completely isolated fluid path. Dimpled jacketing on the plates helps to create a turbulent flow and maximizes heat transfer.

A new mixer will also be introduced as part of ASI’s imPULSE Single-Use Mixing line. The imPULSE MDS has all the same attributes of the traditional imPULSE line including the patented mixing disc that provides thorough mixing throughout the vessel but has been designed as a docking/mixing system with a shippable mixing vessel.

Source: ASI–Life Sciences

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here